Skip to content 
The reference* for antigen tests
A study carried out at the Virology Department of Hôpital Henri Mondor (AP-HP) evaluated 22 antigenic tests on more than 1,157 samples and 4 variants.
COVID-VIRO® is therefore considered to be :
“The reference test that showed excellent sensitivity and specificity (COVID – VIRO, AAZ) was used as a comparator “*.
In addition:
“The sensitivities of the 22 antigenic tests vary from 59.7% … to 100% for AAZ” **
Detects the new Eris and Pirola variants.
Packaging : box of 20 tests
*Fourati, S. et al. Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Infl uence of Variants of Concern : Implications for Clinical Use. Microbiology Spectrum, 10(4). Août 2022. ** Ct ≤ 25
Demonstration video
Instructions for use
Legal information
COVID-VIRO® is a rapid assay for the qualitative detection of SARS-CoV-2 antigen for use by healthcare professionals.
This test is reliable for the detection of SARS-CoV-2 infections during the incubation period that can range from 1 to 14 days but is usually 3 to 7 days.
Read the instructions in the package insert carefully.
Manufactured and distributed by : AAZ-LMB 43 rue de Bellevue 92100 Boulogne-Billancourt, FRANCE
This in vitro diagnostic medical device is a regulated health product which, under these regulations, bears the CE mark.
Internal page reference : AAZ.CV.27-A
Date : 23 October 2020
